A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James S McClellan, MD, PhD
Orca Biosystems, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
Recruiting - Uc Davis
Sacramento, California, United States
Recruiting - Stanford Health Care
Stanford, California, United States
Recruiting - Moffitt Cancer Center
Tampa, Florida, United States
Recruiting - Emory University
Atlanta, Georgia, United States
Active, not recruiting - the University of Kansas Hospital
Kansas City, Kansas, United States
Withdrawn - John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Ohio State University
Columbus, Ohio, United States
Active, not recruiting - University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting - Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Apr 2019
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 300
- Registry id
- NCT03802695
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.